Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Carleton

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Immunity|December 20, 2014
Noncanonical mode of ERK action controls alternative αβ and γδ T cell lineage fatesSang-Yun Lee, Francis Coffey, Shawn P Fahl, et al.
Journal of Biomolecular Screening|July 13, 2012
A multiplexed siRNA screening strategy to identify genes in the PARP pathwayErica Stec, Louis Locco, Stacey Szymanski, et al.
Molecular and Cellular Biology|January 24, 2007
Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progressionPeter S Linsley, Janell Schelter, Julja Burchard, et al.
Cell Cycle (Georgetown, Tex.)|August 5, 2009
MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNTZhan Zhang, Hong Sun, Hongyue Dai, et al.
JAMA Oncology|May 22, 2020
Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: The CheckMate 143 Phase 3 Randomized Clinical TrialDavid A Reardon, Alba A Brandes, Antonio Omuro, et al.
Nature Medicine|May 15, 2020
Elevated serum interleukin-8 is associated with enhanced intratumor neutrophils and reduced clinical benefit of immune-checkpoint inhibitorsKurt A Schalper, Michael Carleton, Ming Zhou, et al.
Molecular and Cellular Biology|September 27, 2006
Small interfering RNA screens reveal enhanced cisplatin cytotoxicity in tumor cells having both BRCA network and TP53 disruptionsSteven R Bartz, Zhan Zhang, Julja Burchard, et al.
Immunity|April 15, 2020
CXCR1 and CXCR2 Chemokine Receptor Agonists Produced by Tumors Induce Neutrophil Extracellular Traps that Interfere with Immune CytotoxicityÁlvaro Teijeira, Saray Garasa, María Gato, et al.
Science Translational Medicine|April 24, 2015
A technology platform to assess multiple cancer agents simultaneously within a patient's tumorRichard A Klinghoffer, S Bahram Bahrami, Beryl A Hatton, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Immunity|December 20, 2014
Noncanonical mode of ERK action controls alternative αβ and γδ T cell lineage fatesSang-Yun Lee, Francis Coffey, Shawn P Fahl, et al.
Journal of Biomolecular Screening|July 13, 2012
A multiplexed siRNA screening strategy to identify genes in the PARP pathwayErica Stec, Louis Locco, Stacey Szymanski, et al.
Molecular and Cellular Biology|January 24, 2007
Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progressionPeter S Linsley, Janell Schelter, Julja Burchard, et al.
Cell Cycle (Georgetown, Tex.)|August 5, 2009
MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNTZhan Zhang, Hong Sun, Hongyue Dai, et al.
JAMA Oncology|May 22, 2020
Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: The CheckMate 143 Phase 3 Randomized Clinical TrialDavid A Reardon, Alba A Brandes, Antonio Omuro, et al.
Nature Medicine|May 15, 2020
Elevated serum interleukin-8 is associated with enhanced intratumor neutrophils and reduced clinical benefit of immune-checkpoint inhibitorsKurt A Schalper, Michael Carleton, Ming Zhou, et al.
Molecular and Cellular Biology|September 27, 2006
Small interfering RNA screens reveal enhanced cisplatin cytotoxicity in tumor cells having both BRCA network and TP53 disruptionsSteven R Bartz, Zhan Zhang, Julja Burchard, et al.
Immunity|April 15, 2020
CXCR1 and CXCR2 Chemokine Receptor Agonists Produced by Tumors Induce Neutrophil Extracellular Traps that Interfere with Immune CytotoxicityÁlvaro Teijeira, Saray Garasa, María Gato, et al.
Science Translational Medicine|April 24, 2015
A technology platform to assess multiple cancer agents simultaneously within a patient's tumorRichard A Klinghoffer, S Bahram Bahrami, Beryl A Hatton, et al.
Pageof 2